Tudor Investment Corp Portfolio holdings
AUM
$13.2B
1-Year Return
6.99%
This Quarter Return
+4.45%
1 Year Return
+6.99%
3 Year Return
+37.99%
5 Year Return
+86.9%
10 Year Return
+285.99%
AUM
$6.13B
AUM Growth
+$860M
(+16%)
Cap. Flow
+$712M
Cap. Flow
% of AUM
11.62%
Top 10 Holdings %
Top 10 Hldgs %
12.44%
Holding
2,141
New
436
Increased
487
Reduced
484
Closed
457
Top Buys
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$82M |
| 2 |
Microsoft
MSFT
|
+$76M |
| 3 |
LSI
Life Storage, Inc.
LSI
|
+$71.2M |
| 4 |
Meta Platforms (Facebook)
META
|
+$68.8M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$65.4M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
+$33.5M |
| 2 |
Colgate-Palmolive
CL
|
+$32.9M |
| 3 |
Phillips 66
PSX
|
+$31.1M |
| 4 |
S&P Global
SPGI
|
+$30.4M |
| 5 |
Honeywell
HON
|
+$23.4M |
Sector Composition
| 1 | Technology | 21% |
| 2 | Healthcare | 12.81% |
| 3 | Industrials | 12.31% |
| 4 | Consumer Discretionary | 11.6% |
| 5 | Financials | 11.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXDR
1401
Nextdoor Holdings
NXDR
$775M
| $151K | ﹤0.01% |
46,436
-63
| -0.1% | -$205 |
|
|
RTL
1402
DELISTED
The Necessity Retail REIT, Inc. Class A Common Stock
RTL
| $149K | ﹤0.01% |
22,057
+2,925
| +15% | +$19.8K |
|
1403
RPC Inc
RES
$1.03B
| $149K | ﹤0.01% |
+20,770
| New | +$149K |
|
1404
Aspen Aerogels
ASPN
$535M
| $147K | ﹤0.01% |
18,614
-155,970
| -89% | -$1.23M |
|
|
ORC
1405
Orchid Island Capital
ORC
$1.04B
| $142K | ﹤0.01% |
+13,708
| New | +$142K |
|
1406
SunCoke Energy
SXC
$657M
| $141K | ﹤0.01% |
+17,964
| New | +$141K |
|
1407
Macerich
MAC
$4.59B
| $137K | ﹤0.01% |
+12,120
| New | +$137K |
|
|
SNPO
1408
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
| $136K | ﹤0.01% |
11,640
-5,275
| -31% | -$61.5K |
|
1409
RLX Technology
RLX
$3.25B
| $134K | ﹤0.01% |
+75,700
| New | +$134K |
|
1410
Senseonics Holdings
SENS
$364M
| $133K | ﹤0.01% |
174,383
| – | – |
|
1411
FibroGen
FGEN
$48M
| $131K | ﹤0.01% |
1,948
-52
| -3% | -$3.51K |
|
1412
Scholar Rock
SRRK
$3.06B
| $131K | ﹤0.01% |
17,422
+4,082
| +31% | +$30.8K |
|
1413
Akebia Therapeutics
AKBA
$785M
| $130K | ﹤0.01% |
142,274
| – | – |
|
1414
Nurix Therapeutics
NRIX
$699M
| $130K | ﹤0.01% |
12,991
-9,115
| -41% | -$91.1K |
|
1415
Design Therapeutics
DSGN
$354M
| $130K | ﹤0.01% |
20,561
-7,078
| -26% | -$44.6K |
|
1416
Cato Corp
CATO
$89.6M
| $126K | ﹤0.01% |
15,750
-18,415
| -54% | -$148K |
|
1417
Definitive Healthcare
DH
$422M
| $124K | ﹤0.01% |
11,309
-93,214
| -89% | -$1.03M |
|
1418
Kearny Financial
KRNY
$416M
| $121K | ﹤0.01% |
17,115
-39,747
| -70% | -$280K |
|
1419
Blend Labs
BLND
$1.11B
| $120K | ﹤0.01% |
126,767
-29,448
| -19% | -$27.9K |
|
1420
AbCellera Biologics
ABCL
$1.38B
| $118K | ﹤0.01% |
18,247
+175
| +1% | +$1.13K |
|
|
BGRY
1421
DELISTED
Berkshire Grey, Inc. Class A Common Stock
BGRY
| $117K | ﹤0.01% |
83,139
| – | – |
|
|
AXDX
1422
DELISTED
Accelerate Diagnostics
AXDX
| $114K | ﹤0.01% |
14,114
| – | – |
|
1423
SGHC Ltd
SGHC
$6.35B
| $112K | ﹤0.01% |
38,751
| – | – |
|
1424
Lexicon Pharmaceuticals
LXRX
$403M
| $111K | ﹤0.01% |
48,585
+37,585
| +342% | +$86.1K |
|
1425
Kodiak Sciences
KOD
$519M
| $111K | ﹤0.01% |
+16,027
| New | +$111K |
|